Metabolism of digoxin and digoxigenin digitoxosides in rat liver microsomes: involvement of cytochrome P4503A
- 1 January 1999
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 29 (2) , 171-185
- https://doi.org/10.1080/004982599238722
Abstract
1. The sequential metabolism of digoxin (Dg3) to digoxigenin bis-digitoxoside (Dg2), digoxigenin mono-digitoxoside (Dg1) and digoxigenin (Dg0) was investigated in rat liver microsomes. 2. Kinetic studies produced results consistent with a single enzyme mechanism describing the successive oxidative cleavages. Formation of Dg2 was catalysed with mean (SD) Km and Vmax of 125 22 muM and 362 37/pmol/min/mg/protein, respectively. The corresponding values for the formation of Dg1 were 61 5 muM and 7 1 pmol/min/mg/protein. Dg0 formation was catalysed with the apparent values of 30 9 muM and 310 30 pmol/min/mg/protein. 3. Chemical inhibition of cytochrome P450 (CYP) 3Asubfamily with ketoconazole and triacetyoleandomycin decreased the formation of Dg2 and Dg1 by up to 90%. Antibodies specific to rat CYP3A2 lowered the rate of oxidative cleavage of Dg3 and Dg2 by up to 85%. Inhibition of CYP2E1, CYP2C subfamily and CYP1A2 by chemical and immunoinhibition did not affect initial rates of metabolism of Dg3 and Dg2. In contrast, Dg1 metabolism was not affected by triacetyloleandomycin as well as by antibodies to CYP3A2, CYP2C11, CYP2E1, CYP2B1 2B2 and CYP1A2. It was however inhibited by 80% by gestodene and 17 alpha -ethynylestradiol (selective inhibitors of human CYP3A). 4. Collectively, these data support the involvement of CYP3A in the cleavage of Dg3 and Dg2 in rat liver microsomes. The enzyme-metabolizing Dg1 remains to be identified.Keywords
This publication has 13 references indexed in Scilit:
- Stereoselective Inhibition by the Diastereomers Quinidine and Quinine of Uptake of Cardiac Glycosides into Isolated Rat HepatocytesJournal of Pharmaceutical Sciences, 1998
- Expression and Inducibility of Cytochrome P450 3A9 (CYP3A9)and Other Members of the CYP3A Subfamily in Rat LiverArchives of Biochemistry and Biophysics, 1997
- Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P‐glycoprotein: Implications for drug delivery and activity in cancer chemotherapyMolecular Carcinogenesis, 1995
- Metabolism of digoxin, digoxigenin digitoxosides and digoxigenin in human hepatocytes and liver microsomesFundamental & Clinical Pharmacology, 1991
- Cardiac glycosides: New/old ideas about old drugsBiochemical Pharmacology, 1990
- Mechanism-based inactivation of human liver microsomal cytochrome P-450 IIIA4 by gestodeneChemical Research in Toxicology, 1990
- Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man.British Journal of Clinical Pharmacology, 1990
- Pharmacokinetic Interactions with DigoxinClinical Pharmacokinetics, 1988
- Influence of gastric pH on digoxin biotransformationClinical Pharmacology & Therapeutics, 1981
- Influence of gastric pH on digoxin biotransformationClinical Pharmacology & Therapeutics, 1980